Haemonetics
Results: 64
| # | Item |
|---|---|
61![Summary Basis of Approval OB-NDA[removed]Product:](https://www.pdfsearch.io/img/ee2f71304832e97a875b3e68099e31d6.jpg "Summary Basis of Approval OB-NDA[removed]Product:") | Summary Basis of Approval OB-NDA[removed]Product:Add to Reading ListSource URL: www.fda.govLanguage: English |
62 | K020059 - Summary of Safety and EffectivenessAdd to Reading ListSource URL: www.fda.govLanguage: English |
63![FIling Year[removed]Significantly Regulated) Listing of U.S. Industries Company Haemonetics Corporation Hain Celestial Group Inc Halozyme Therapeutics, Inc. Hansen Medical, Inc.](https://www.pdfsearch.io/img/c8f62a5030f958ab9b7a7795cf16fe3d.jpg "FIling Year[removed]Significantly Regulated) Listing of U.S. Industries Company Haemonetics Corporation Hain Celestial Group Inc Halozyme Therapeutics, Inc. Hansen Medical, Inc.") | FIling Year[removed]Significantly Regulated) Listing of U.S. Industries Company Haemonetics Corporation Hain Celestial Group Inc Halozyme Therapeutics, Inc. Hansen Medical, Inc.Add to Reading ListSource URL: www.fda.govLanguage: English |
64 | IMDRF - Presentation - Regulatory guidance for validation and approval of standardized apheresis connectorsAdd to Reading ListSource URL: www.imdrf.orgLanguage: English - Date: 2013-04-11 00:27:09 |